Author: Sai Krishna

A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%

PARIS, Sept. 17, 2026 /PRNewswire/ — 

• H1 2026 delivered a robust revenue growth of +7.4% and an adjusted EBIT margin of 18.8% at CERS:

○  Revenue growth is coming from both segments : companion animal +10.0% and farm animal +6.7% with a strong contribution from our Supercharge platforms (excl. Thyronorm) which increased by around +12% at CERS

○  Solid volume/mix effect of ~+5.4%, completed by price increase of ~+2%

○  Operating margin increased by 0.5ppt compared to H1 2025 driven by a favorable mix effect on the gross margin partially offset by higher operating expenses due to H1/H2 phasing effects.

• Consolidated net income increased by +5.9% to €87.1 million
• Net Debt as of June 2026 up to €196 million compared to €173m as of December 2025 mainly driven by usual working capital requirement seasonality

2026 guidance confirmed at the upper end of the range: the strong performance achieved in the first half of the year positions us to target the upper end of our initial revenue growth range (5.5% to 7.5% at CERS) and an adjusted recurring operating income margin of around 17% at CERS



Paul Martingell, Chief Executive Officer statement

“Virbac delivered a strong first half, marked by +7.4% organic growth and an 18.8% operating margin, demonstrating our teams’ ability to turn our commitment to animal health into tangible value. This performance reflects the scaling power of our ‘Supercharge’ platforms and the seamless integration of Thyronorm. Guided by our ‘Growing Together’ 2030 strategy, we are fully on track to achieve our full-year guidance.”

To be noted: EBIT Adjusted (before amortizations) corresponds to “recurring operating income before amortization of assets arising from acquisitions”.

Media Contact: contact@virbac.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/a-robust-adjusted-ebit-margin-of-18-8-driven-by-solid-organic-revenue-growth-of-7-4-302882343.html

ZEISS expands retinal imaging portfolio with new ZEISS ALTA DUO 300

ZEISS’ new multimodal solution combines automated OCT and fundus imaging to support simplified and efficient retinal assessment across a broader range of eye care practices.

JENA, Germany, Sept. 17, 2026 /PRNewswire/ — ZEISS Medical Technology, one of the world’s leading medical technology companies, announced the expansion of its retinal imaging portfolio with the ZEISS ALTA DUO fully automated, compact, multimodal imaging solution. Combining OCT and fundus photography within a single imaging device, the new solution broadens the ZEISS retinal imaging offering and helps address the needs of practices seeking efficient access to multimodal retinal imaging. Eye care practices operate with different clinical priorities, workflow requirements and patient volumes. The introduction of ZEISS ALTA DUO 300 expands the range of retinal imaging solutions available from ZEISS, enabling eye care professionals to select the imaging platform that best aligns with their practice needs.

The ZEISS ALTA DUO 300 will be showcased at the European Society of Retina Specialists (EURETINA) congress in Vienna, Austria, from Oct. 1 – 4 and will be available in select markets later in 2026.

“With the introduction of the ZEISS ALTA DUO 300, we deliver new customer value by expanding our ZEISS retinal imaging portfolio for eye care professionals, whose needs vary, depending on the patients they serve and services they provide. The ALTA DUO adds an alternative fully automated, multimodal device to the ZEISS OCT portfolio, complementing the comprehensive CIRRUS solution,” says Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology.

“Many practices are looking for ways to integrate retinal imaging into everyday patient care through workflows that are efficient, consistent and easy to adopt. By bringing OCT and fundus imaging together with automated acquisition capabilities, ZEISS ALTA DUO 300 helps address those needs while allowing practices to benefit from the broader ZEISS ophthalmic portfolio,” says Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology.

ZEISS ALTA DUO multimodal, fully automated OCT, simplified

The ZEISS ALTA DUO 300 is built around four key diagnostic technologies, combined into one automated device that enables users to achieve consistent results with ease. The device offers a fully automated structural OCT with a robust reference database and comprehensive reporting, combined with a true color fundus camera. It also includes high resolution AI enhanced OCT-Angiography capability together with full chamber depth anterior OCT scan capability (without the need for external lens applications), providing eye care professionals with multiple diagnostic functionalities in one simple device.

To learn more about the ZEISS ALTA DUO 300, visit the ZEISS booth B50 in Hall B at the European Society of Retina Specialists (EURETINA) congress in Vienna, Austria, from Oct. 1 – 4.

Not all products, services or offers are approved or offered in every market and approved labelling and instructions may vary from one country to another. For country specific product information, see the appropriate country website. 

Company Profile

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the TecDAX and SDAx of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,784 employees worldwide, the Group generated revenue of €2,228m in fiscal year 2024/25 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For further information visit: www.zeiss.com/med.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/zeiss-expands-retinal-imaging-portfolio-with-new-zeiss-alta-duo-300-302881596.html

American Savings Bank Jumps More Than 6% in Trading Debut: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, Sept. 17, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on September 17th

• American Savings Bank scored a winning debut as a publicly traded company.
  • Shares of the American Savings Bank (NYSE: ASBH) rose 6.25% on Wednesday.
  • On NYSE Live, CEO Ann Teranishi discussed the level of responsibility the firm has to support the needs of its customers.
• The Federal Reserve raised interest rates for the first time since 2023.
  • The central bank raised interest rates by 25 basis points, while policymakers signaled another rate hike could take place later this year.
  • In his news conference, Fed Chair Kevin Warsh emphasized that inflation remains too high.
• Profound secured a $180 million Series D raise earlier this week.
  • The round boosted Profound’s valuation to $1.8 billion
  • Co-founder + CEO James Cadwallader will join NYSE Live to explain how his platform Is uniquely built to win in the era of emerging technologies.
• Sequen AI recently raised $90 million in Series B funding.
  • The company elevated its valuation to $1.44 billion.
  • The behavioral AI and enterprise software startup is launching Recursive Ranking Intelligence (RRI), an autonomous AI researcher.

Opening Bell

The New York Times (NYSE: NYT) marks 175 years since its founding.

Closing Bell

Nomura Holdings (NYSE: NMR) marks 100 years since its founding.

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App and check out the NYSE YouTube: TV.NYSE.com and YouTube.com/@NYSEofficial

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/american-savings-bank-jumps-more-than-6-in-trading-debut-nyse-content-update-302882094.html

Cyble and Cyber Security Council of UAE Sign MOU to Strengthen National Threat Intelligence Capabilities

ABU DHABI, UAE, Sept. 17, 2026 /PRNewswire/ — Cyble, a global AI-native cybersecurity company, today announced the signing of a Memorandum of Understanding (MOU) with the Cyber Security Council of the United Arab Emirates (UAE), the federal entity responsible for strengthening the UAE’s cybersecurity posture. The agreement formalizes a strategic collaboration centered on Cyble’s threat intelligence capabilities, marking a significant milestone in Cyble’s engagement with the UAE’s national cybersecurity ecosystem.

The MOU establishes a framework for Cyble to support the Council’s mission of protecting UAE’s digital infrastructure, with a focus on delivering advanced threat intelligence, early warning capabilities, and actionable insights into emerging cyber risks facing government and critical-infrastructure entities across the country.

This collaboration reflects the UAE’s continued commitment to building a resilient, forward-looking cybersecurity posture at the national level, and positions Cyble as a trusted technology partner within that effort. By working closely with the Council, Cyble aims to help strengthen visibility into threat actors, malicious campaigns, and vulnerabilities that could impact the UAE’s most critical systems and services.

“This is not just a partnership announcement. It is a strategic validation of Cyble’s capabilities at the national cybersecurity level and potentially a gateway to the UAE government and critical-infrastructure ecosystem,” said Beenu Arora, CEO and Co-Founder, Cyble. “Working alongside the Cyber Security Council underscores the trust placed in our threat intelligence platform and reflects the growing importance of proactive, intelligence-led defense in protecting nations against increasingly sophisticated cyber threats.”

“The Cyber Security Council is committed to building strategic partnerships with world-class technology providers that strengthen the UAE’s cyber resilience at every level,” said H.E. Dr. Mohamed Al Kuwaiti, Head of Cyber Security for the UAE. “This MOU with Cyble reflects our shared commitment to safeguarding the nation’s digital infrastructure through advanced threat intelligence and proactive, intelligence-led defense — ensuring the UAE remains at the forefront of global cybersecurity readiness.”

The agreement builds on Cyble’s broader strategy of deepening engagement with government and regulatory bodies across the Middle East, reinforcing its position as a trusted partner to national cybersecurity authorities navigating an increasingly complex threat landscape.

Cyble’s threat intelligence platform, Cyble Vision, powered by Blaze AI, will play a central role in the collaboration — delivering rapid detection, automated analysis, and contextual insights into ransomware, phishing, fraud, and other evolving threats relevant to national security priorities.

About Cyble

Cyble is a global, AI-native cybersecurity company specializing in threat intelligence, digital risk protection, and dark web monitoring. Its flagship platform, Cyble Vision, powered by Blaze AI, delivers rapid threat detection, automated analysis, and contextual insights into ransomware, phishing, and fraud.

Media Contacts:

enquiries@cyble.com

+1 678 379 3241

www.cyble.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cyble-and-cyber-security-council-of-uae-sign-mou-to-strengthen-national-threat-intelligence-capabilities-302882097.html

Huawei Introduces OceanStor M900 Context Memory Storage to Accelerate AI Inference in Hyperscale Data Centers

SHANGHAI, Sept. 17, 2026 /PRNewswire/ — At HUAWEI CONNECT 2026, David Wang, Deputy Chairman of the Board and Rotating Chairman at Huawei, officially introduced OceanStor M900 Context Memory Storage during his keynote. Designed for AI inference in hyperscale data centers, the product provides SuperPoDs with a fully shared memory space that offers PB-scale capacity and TB/s-level performance. This marks a shift in AI infrastructure from a compute-centric model to deep collaboration among compute, network, and storage. This will help unleash the computing power of SuperPoDs.

2026 has seen the accelerated transition of AI from technological breakthroughs to large-scale implementation. AI applications have evolved from chatbots to agents capable of autonomously completing complex tasks. These agents are widely adopted in critical sectors, marking the beginning of the agentic AI era.

As large models grow to 10 trillion-scale parameters, SuperPoDs are becoming the optimal choice for AI infrastructure. Mainstream large models already support context windows exceeding one million tokens, multi-turn inference and complex tasks have become the norm, and KV cache data generated during inference continues to grow. These trends have pushed on-chip memory and DRAM beyond their limits in capacity and cost-effectiveness. It has become an industry consensus to build a multi-tier storage system that coordinates on-chip memory, DRAM, and SSDs to create a fully shared memory space with massive capacity.

Huawei introduced OceanStor M900 Context Memory Storage to overcome the memory capacity bottlenecks in ultra-long context and multi-turn inference. OceanStor M900 uses the UnifiedBus network to build PB-scale, global multi-tier KV cache with one-hop connections. This fully unleashes the computing power potential of SuperPoDs and accelerates AI inference in hyperscale data centers. OceanStor M900 Context Memory Storage has three key capabilities:

Breaking Capacity Boundaries to Empower Large-Scale AI with Massive Memory

Powered by the high-speed UnifiedBus interconnect network, the KV cache achieves global pooling and sharing with tiered storage. The KV cache of SuperPoDs is expanded from on-chip memory and DRAM to SSDs, enabling a single cluster to deliver 64 PB of capacity. The available KV cache capacity per NPU is upgraded from gigabytes to terabytes, allowing more context to be stored, shared, and reused. This significantly boosts the KV cache hit ratio.

Boosting Inference Performance to Fully Unleash Computing Power

OceanStor M900 is the industry’s first architecture to integrate the CPU, network controller unit, and NAND controller unit. It provides native KV semantics to enable one-hop connection from the SuperPoD’s NPU to SSDs. This eliminates the need for protocol conversion and CPU forwarding, slashing access latency from milliseconds to 60 microseconds, a 90% reduction. A single cluster delivers 40 TB/s of aggregate access bandwidth, 1.5 times higher than peer solutions. In typical AI programming scenarios, this architecture doubles the inference cluster’s token throughput and halves the time to first token, converting computing power into productivity.

Lowering Token Costs to Enable  Economical Large-Scale AI Adoption

OceanStor M900 uses the industry’s first KV-aware adaptive storage technology, which predicts KV cache lifecycles based on data value and intelligently distributes data across storage media. This technology enables up to 24 drive writes per day (DWPD), extending SSD endurance by 16 times and ensuring stability for three years. By reducing media replacement and O&M costs, it lowers the long-term costs of large-scale AI inference infrastructure and enables faster AI adoption.

As AI expands into major production systems in all manner of industries, AI infrastructure is evolving from a compute-centric model toward tighter compute-network-storage collaboration. Context memory storage will be essential for continually enhancing the capacity and access efficiency of hyperscale inference KV caches.

View original content:https://www.prnewswire.co.uk/news-releases/huawei-introduces-oceanstor-m900-context-memory-storage-to-accelerate-ai-inference-in-hyperscale-data-centers-302882127.html

Cellebrite Expands Global Digital Community, ‘The 101’, for Digital Forensics and Investigative Professionals

Purpose-built platform connects customers worldwide with peers and Cellebrite experts into an always-on community

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 17, 2026 /PRNewswire/ — Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered digital investigative and intelligence solutions for the public and private sectors, today announced the expansion of The 101, a purpose-built global digital community for digital forensics and investigative professionals available to customers through the MyCellebrite portal. The community is growing daily from a base of 62-thousand users who are in active discussion groups, asking questions and sharing knowledge with peers and Cellebrite experts around the world.

Every day, digital forensics and investigative professionals use Cellebrite technology to uncover insights, advance investigations and help make their communities safer. The 101 is designed to help them get more from Cellebrite’s solutions, its experts and each other, so they can reach those outcomes even faster. Customers can join sub-communities based on products and experience, participate in discussions, share best practices and access resources and technical updates relevant to their work.

“When I finished my own digital forensics training, I went straight into a difficult case and while I had the basics, I had no easy way to build a network or even connect with someone who had seen it before,” said Jared Barnhart, who leads Cellebrite’s Global Customer Engagement Team. “The 101 is the solution I wish I’d had: an always-on place to ask questions, stay curious and get answers from Cellebrite experts and practitioners across the world. We have expanded and enhanced the 101 so our user community can learn together, and we’re inviting every customer to explore it, share their knowledge and help it grow.”

“Every customer relationship we have starts with a shared mission: helping them find the truth faster so they can keep their communities safe,” said Marcus Jewell, chief revenue officer, Cellebrite. “The 101 puts that mission into practice every day, giving customers a direct line to our experts and to one another. When our customers succeed, we succeed — and this community is one of the clearest ways we can support them.”

Feedback from customers who have recently visited The 101 describe it as a natural extension of the trust-but-verify mindset central to digital forensics and investigative work. The community is getting praise for its focused discussion threads, ease of use in tracking questions and one’s own contributions and the sub-communities for investigators, newcomers and practitioners exploring how AI fits into their workflow.

Cellebrite customers can explore The 101 by logging in through MyCellebrite. Following an in-person celebratory launch with local customers at Cellebrite’s U.S. Headquarters on September 16, 2026, The 101 Community members can look forward to the ultimate networking and peer connection event at the annual Global C2C User Summit, taking place April 12-16, 2027 at the Hilton Anatole in Dallas, Texas.

ABOUT CELLEBRITE

Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency, and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com/investors and find us on social media @Cellebrite.

Media

Jackie Labrecque 

Director, PR and Executive Communications 

jackie.labrecque@cellebrite.com   

+1 771.241.7010

Investors Relations 

Andrew Kramer

Vice President, Investor Relations & Treasury 

investors@cellebrite.com

+1 973.206.7760

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cellebrite-expands-global-digital-community-the-101-for-digital-forensics-and-investigative-professionals-302881943.html

ATOME PLC: Notice of Dispute and Intent to Submit Claim to Arbitration under the UK – Paraguay Bilateral Investment Treaty (“the Treaty” or “BIT”)

Claim independently assessed to be very substantial

LONDON, Sept. 17, 2026 /PRNewswire/ — ATOME, the leading low-carbon fertiliser developer and the UK’s only dedicated international industrial scale low-carbon fertiliser company, provides an update further to previous announcements regarding the Power Purchase Agreement (“PPA”) for the Villeta Project in Paraguay (“Villeta” or “Project”).

ATOME remains in discussions relating to ATOME’s shovel ready Villeta Project, the largest single foreign industrial investment in the history of Paraguay totaling US$665 million. Notwithstanding this, ATOME as a public company, having received positive legal advice, is mindful of its responsibilities to its shareholders and its obligations to protect its legitimate rights.

Against this background on 17 September 2026, ATOME PLC, through White & Case LLP, will today serve a Notice of Dispute and Intent to Submit a Claim to Arbitration on the Republic of Paraguay (“the Notice”) pursuant to the Agreement between the Government of the United Kingdom of Great Britain and Northern Ireland and the Government of Paraguay for the Promotion and Protection of Investments (“the BIT”). 

The Notice states that an investment dispute exists as a result of Paraguay’s alleged acts and omissions in violation of the BIT, including its revocation of the Presidential Decrees issued by the Paraguayan State that supported the Project and provided certainty on term and price under the PPA.

The Notice urges the Paraguayan State to engage in discussions to amicably resolve the matter. 

The UK Government has been informed of the submission of the Notice as has the Embassies of the EU, France, Germany and the United States in Paraguay as well as the Paraguayan Embassy in London. In accordance with the BIT, the Notice states if the dispute has not been resolved within a period of three months i.e. a viable resolution not achieved ATOME will pursue its claim under the BIT against Paraguay at the International Centre for Settlement of Investment Disputes in Washington D.C.

If allowed to be completed, the Project would make Paraguay a world leader in the production of green fertiliser and the fertiliser industry in South America, strengthening local and international food security, creating some 4,000 jobs during construction and over 1,000 jobs during operations, and making material contributions to the country’s GDP and economy.

ATOME will continue to make constructive efforts to amicably resolve the relevant issues but will pursue its rights under international law if it deems necessary.

ATOME will continue to keep the market informed at all material times and in the meantime all other projects of ATOME continue unaffected. 

For more information, please visit https://www.atomeplc.com

About ATOME 

ATOME PLC is an AIM-listed company leading the international development of green fertiliser with a pipeline of projects across Latin America.

ATOME’s projects are situated at the heart of one of the world’s largest food export hubs – the Mercosur region in the Southern Cone of South America with the Argentinian and Brazilian markets next door. ATOME’s production will disrupt the region’s heavy dependence on imported fossil fuel generated fertiliser, contributing to regional food security goals.

In May 2026, ATOME declared unconditional Final Investment Decision on its flagship Villeta Project, Paraguay following the completion of US$665 million project finance backed by leading international development finance institutions and private infrastructure investors including IDB Invest, the Inter-American Development Bank’s (“IDB”) private sector lending arm; the International Finance Corporation (“IFC”), the World Bank Group’s private sector lending arm; the Dutch Entrepreneurial Development Bank (“FMO”); the European Investment Bank (“EIB”), the lending arm of the European Union; the Green Climate Fund, which is administered by the World Bank; the German Investment Corporation (“DEG”), a subsidiary of KfW, Germany’s State-owned investment and development bank; Impact Fund Denmark, an investment arm of the Danish Government; and Hy24, the world’s first and largest hydrogen private equity asset manager.

The Villeta Project benefits from a minimum 10-year Definitive Offtake Agreement signed with Yara International, the leading international fertiliser company, for offtake of all of Villeta’s green fertiliser production, as well as a US$465 million fixed-price EPC contract with leading ammonia and fertiliser engineering specialist Casale S.A.

Roughly a third of human caused GHG emissions is linked to food production according to UN data, and fertiliser use and production is the source of more emissions than the shipping and aviation industries combined. ATOME’s green Calcium Ammonium Nitrate product will contribute to decarbonising the food sector from the bottom up, getting to the root of the food value chain’s emissions. ATOME’s renewably generated fertiliser is both low-carbon and provides a secure, stable alternative product not reliant on fossil fuels, unlike all nitrogen fertiliser production today.

The Company has a green-focused Board which is supported by major shareholders including Peter Levine, Schroders, a leading fund manager, Baker Hughes, a global energy technology company operating in the energy and industry sectors and Casale S.A, the Swiss-based ammonia and fertiliser specialist engineering firm and technology licensor.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/atome-plc-notice-of-dispute-and-intent-to-submit-claim-to-arbitration-under-the-uk–paraguay-bilateral-investment-treaty-the-treaty-or-bit-302881984.html

HR Path Strengthens Its Dayforce Capabilities in the UK & Ireland with the Acquisition of ModusForce

PARIS, Sept. 17, 2026 /PRNewswire/ — HR Path, a global leader in HR consulting and HRIS solutions, is proud to announce its strategic acquisition of ModusForce, a UK-based company specialising in Dayforce and Dayforce HCM consulting, Payroll and Workforce Management, further reinforcing its presence across the UK & Ireland markets.

With a presence in 34 countries and a team of approximately 2,900 professionals, HR Path is a trusted partner for businesses navigating the complexities of Human Resources. Specialising in advisory, implementation, and operational services, HR Path delivers cutting-edge solutions designed to enhance efficiency and foster growth. Since its founding in 2001, the company has remained steadfast in its mission to transform HR practices globally.

Since its launch, ModusForce has established itself as a trusted Dayforce consultancy, helping organisations transform and optimise HR, Payroll and Workforce Management. Through advisory, implementation, change, optimisation and managed support services, ModusForce combines deep Dayforce expertise with a practical, delivery-focused approach to help clients maximise the value of their investment.

This acquisition represents a significant milestone for HR Path, reinforcing its leadership in the HR industry and expanding its presence in the United Kingdom and Ireland. ModusForce’s specialised focus on Dayforce perfectly complements HR Path’s ambition to drive organisational growth and excellence through strategic HR solutions.

The acquisition of ModusForce strengthens HR Path’s ability to cover the entire United Kingdom & Ireland markets with deeper Dayforce expertise across HCM, Workforce Management and Payroll. It follows the acquisitions of Three Plus Consulting in 2024, a UK-based Workday specialist; IntSys in 2025, a Northern Ireland-based company specialising in Workday integration and HR technology services; and Eaton Square in 2025, an Ireland and UK-based consulting firm specialising in Technology, People and Business Consulting, with expertise across Dayforce, UKG, Workday, Access, HiBob, Sage and Microsoft. Together, these strategic moves ensure a comprehensive presence and delivery capability throughout the region.

“The acquisition of ModusForce is a strategic move that supports our ambition to be the global reference in HR transformation,” said Chris Howarth, Partner at HR Path. “Their deep Dayforce expertise and strong client relationships in the UK & Ireland complement our global capabilities, enabling us to deliver even more value to our clients. This partnership is not only about growth – it’s about synergy, innovation, and shared commitment to excellence.”

Contact:

Fabienne LATOUR – Fabienne.latour@hr-path.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/hr-path-strengthens-its-dayforce-capabilities-in-the-uk–ireland-with-the-acquisition-of-modusforce-302880590.html

L’OCCITANE Group achieves a new milestone in its B Corp™ certification journey

Progress is measured not only by what is achieved, but by the commitment to keep improving.

GENEVA, Sept. 17, 2026 /PRNewswire/ — Today, L’OCCITANE Group is proud to announce further progress in its B Corp™ certification journey under B Lab™’s new Standards, with entities within the Group’s certification perimeter achieving certification or recertification under the new Standards. This marks a significant milestone in the Group’s ongoing work to strengthen its practices across governance, people and environmental topics.

The accomplishment follows the Group’s first certification in 2023 and recognises the progress made over the past three years. More importantly, it marks the next stage of a continuous improvement journey under a significantly more rigorous certification framework.

Across its portfolio, the Group continues to advance its B Corp™ journey. A number of entities within the Group have already achieved certification or recertification under the new Standards, with further brands progressing towards their respective certification milestones. These milestones will also be communicated by the individual brands. This reflects the Group’s ongoing commitment to enhancing social and environmental performance across its businesses.

For L’OCCITANE Group, B Corp™ has never been simply about earning a badge of approval. Rather, it provides an independent framework that helps translate long-held values into measurable action, encouraging the Group to improve how it does business every day.

Raphaëlle Archambeaud-Sicot, Group Chief Sustainability Officer, said: “Responsible business is never static. The new framework encourages us to strengthen our governance, deepen our environmental and social impact and continue learning year after year. That spirit of continuous improvement remains at the heart of our approach.”

The new B Lab Standards represent a significant evolution in the way B Corp™ certification is assessed. Under the new Standards, businesses are required to meet specified requirements across seven Impact Topics, subject to the applicable assessment and verification process. Independent third-party audits, periodic subsequent audits, and increasingly rigorous requirements reinforce that being a B Corp™ is an ongoing commitment rather than a one-off achievement.

The Group is proud to be among the first cohort of companies engaging in recertification under the new B Lab Standards, contributing valuable input to the development of the framework and helping to shape the future of responsible business at scale.

Data sourced from the L’OCCITANE Group 2026 ESG Report.

Contact: L’OCCITANE Group, groupcommunication@loccitane.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/loccitane-group-achieves-a-new-milestone-in-its-b-corp-certification-journey-302881948.html

Treating the heart without open-heart surgery: Manipal Hospital Dhakuria performs MitraClip on an 80-year-old woman

KOLKATA, India, Sept. 17, 2026 /PRNewswire/ — An 80-year-old woman from Kolkata, suffering from recurrent heart failure due to severe mitral regurgitation, successfully underwent MitraClip procedure under the expertise of Dr. Prakash Kumar Hazra and Dr. Soumya Kanti Dutta, Interventional Cardiologists at Manipal Hospital Dhakuria . She is the first female patient at the hospital to undergo this procedure that was completed in 30-minutes.

The patient had a history of recurrent hospitalisations for severe lung infections, bilateral pedal edema, and worsening heart failure, despite multiple medications and critical care support. On detailed evaluation, she was found to have severe mitral regurgitation (MR), allowing significant backflow of blood into the left atrium.

MitraClip is an advanced, minimally invasive procedure treatment for selected patients with significant mitral regurgitation (MR) particularly those who may be at high risk for conventional open-heart surgery. Transcatheter Edge-to-Edge Repair (TEER), is performed using a catheter-based approach. The MitraClip device is guided to the heart through a vein and precisely brings together the mitral valve leaflets, thereby reducing the abnormal backward flow of blood. By reducing mitral regurgitation, the procedure can help lower pressure within the lungs, improve symptoms and reduce the burden of heart failure in appropriately selected patients.

Dr. Soumya Kanti Dutta, said, “In patients with multiple comorbidities such as hypothyroidism, hypertension, obesity, diabetes, COPD, renal dysfunction or those who are on multiple medications, it becomes quiet difficult to undergo Mitral Valve replacement with general anaesthesia that needs lots of blood transfusion and a longer hospital stay. MitraClip procedure is minimally invasive, thereby it is an easy and approachable procedure for people who cannot survive or may be at high risk for open-heart surgery.”

Dr. Prakash Kumar Hazra, said, “Following a multidisciplinary heart-team discussion, we decided to perform a minimally invasive transcatheter edge-to-edge repair using MitraClip. Unlike conventional valve replacement, MitraClip procedure is a repair method rather than a replacement, enhancing longevity and reducing complications. It eliminates the necessity for open-heart surgery and blood transfusions, decreases the likelihood of stroke, leaves no scar, and promotes quicker recovery. The procedure can be performed in just 30 to 45 minutes generally associated with a shorter hospital stay compared with conventional surgery.

Unlike mechanical mitral valve repair or replacement that usually requires lifelong anti coagulators, MitraClip procedure diminishes the risk of anti-coagulation since the procedure does not involve the requirement of blood thinner or anti-coagulation unless the patient has atrial fibrillation. Anti-platelets therapy can be stopped within 3 months of the process according to the patient’s clinical profile, thus reducing the bleeding risk in the patients. For people suffering from cancer, renal failure or advance diabetes, MitraClip is one such procedure that prevents recurrent hospitalisation.

The MitraClip procedure was successfully performed, resulting in a significant reduction in mitral regurgitation. The patient recovered well following the procedure and was discharged home within a few days. She is currently stable, comfortable and recovering well at home, following a successful minimally invasive intervention for a condition that had previously resulted in recurrent hospitalisations and worsening heart failure.

About Manipal Hospitals

Manipal Hospitals is one of India’s leading integrated healthcare providers, with a pan-India network of 50 multispecialty hospitals and over 13,000 licensed beds across 14 states and union territories. The network is the country’s largest multispecialty hospital network by bed capacity, supported by more than 11,000 doctors and 25,000 employees.

With a commitment to accessible, high-quality, patient-centric care, Manipal Hospitals combines clinical expertise with advanced technology, research and innovation to serve over 7 million patients annually, including patients from around the world. Its commitment to clinical and operational excellence is reflected in its NABH and AAHRPP accreditations, with several hospitals also accredited by NABL and recognised for excellence in nursing and emergency care.

Photo: https://mma.prnewswire.com/media/3009023/MANIPAL_HOSPITALS_Mitra_Clip.jpg

Logo: https://mma.prnewswire.com/media/2987039/6031618/Manipal_Hospitals_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/treating-the-heart-without-open-heart-surgery-manipal-hospital-dhakuria-performs-mitraclip-on-an-80-year-old-woman-302881919.html